semaglutide and bilirubin 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Semaglutide therapy for metabolic... :
Description
Detailed body composition analysis could help elucidate the metabolic and functional effects of these therapies in this vulnerable population
Retatrutide's fat-to-lean ratio in trials is comparable

If those first two sound familiar, it's because the current generation of weight loss medications already targets them

whether patients achieved HbA 1c 20% increase in total daily insulin dosage) reflects that insulin was freely adjustable during weeks 2652 to reach an HbA 1c 25% for 3.4% ( n = 25), and was unchanged for 12.4% ( n = 90)

If you experience these symptoms, stop Wegovy pills immediately and go to A&E
